Clasp Therapeutics
PrivateLast Round
Series A
Mar 20, 2024
Total Funding Raised
$150M
Momentum Score
25 /100
Company Overview
Clasp Therapeutics, Inc. is a biotechnology company developing next-generation T cell engagers (TCEs) that target tumor-specific oncogenic driver mutations for hard-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clasp Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Clasp Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 20, 2024 |
Key People
Founding team and executive leadership
Clasp Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalio Capital Management | Series A |
| Novo Holdings | Series A |
| Pictet Alternative Advisors | Series A |
| Alexandria Venture Investments | Series A |
| Cure Ventures | Series A |
| Vivo Capital | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2025
Nonclinical data for CLSP-1025 presented at 2025 AACR Annual Meeting.
- Apr 28, 2025
Presented at the 2025 AACR Annual Meeting.
Clasp Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Clasp Therapeutics's valuation, stock price, and market status.
